Cargando…
A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis
Newly diagnosed AL amyloidosis patients were evaluated to develop a model for early assessment of treatment benefit at 6 months, integrating both hematologic (HR) and organ response (OR) assessment (testing cohort, Mayo: n = 473; validation cohort, Pavia: n = 575). Multiple OR were assessed as follo...
Autores principales: | Sidana, Surbhi, Milani, Paolo, Binder, Moritz, Basset, Marco, Tandon, Nidhi, Foli, Andrea, Dispenzieri, Angela, Gertz, Morie A., Hayman, Suzanne R., Buadi, Francis K., Lacy, Martha Q., Kapoor, Prashant, Leung, Nelson, Rajkumar, S. Vincent, Merlini, Giampaolo, Palladini, Giovanni, Kumar, Shaji K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156647/ https://www.ncbi.nlm.nih.gov/pubmed/32286270 http://dx.doi.org/10.1038/s41408-020-0306-5 |
Ejemplares similares
-
The lung in amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017) -
Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy
por: Milani, Paolo, et al.
Publicado: (2020) -
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
por: Pang, Li, et al.
Publicado: (2021) -
Prognostic Significance of Circulating Plasma Cells by Multi-Parametric Flow Cytometry in Light Chain Amyloidosis
por: Sidana, Surbhi, et al.
Publicado: (2018) -
N‐terminal fragment of the type‐B natriuretic peptide (NT‐proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma
por: Milani, Paolo, et al.
Publicado: (2016)